Novo Nordisk Aktie
64,08
EUR
-1,30
EUR
-1,99
%
60,86
CHF
-0,68
CHF
-1,11
%
Werbung
Novo Nordisk Aktie Analyse
09.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
13.02.23 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.02.23 | Novo Nordisk Buy | Deutsche Bank AG | |
02.02.23 | Novo Nordisk Buy | Deutsche Bank AG | |
01.02.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
25.01.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
25.01.23 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
25.01.23 | Novo Nordisk Overweight | Barclays Capital | |
Werbung
|
|||
16.01.23 | Novo Nordisk Buy | Deutsche Bank AG | |
09.01.23 | Novo Nordisk Overweight | Barclays Capital | |
03.01.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
23.12.22 | Novo Nordisk Overweight | Barclays Capital | |
07.12.22 | Novo Nordisk Buy | Deutsche Bank AG | |
14.11.22 | Novo Nordisk Overweight | Barclays Capital | |
08.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.22 | Novo Nordisk Buy | Deutsche Bank AG | |
03.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.11.22 | Novo Nordisk Buy | Deutsche Bank AG | |
02.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
02.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
24.10.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.22 | Novo Nordisk Buy | Deutsche Bank AG | |
14.10.22 | Novo Nordisk Overweight | Barclays Capital | |
07.10.22 | Novo Nordisk Buy | Deutsche Bank AG | |
04.10.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.10.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.10.22 | Novo Nordisk Overweight | Barclays Capital | |
21.09.22 | Novo Nordisk Buy | Deutsche Bank AG | |
22.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
15.08.22 | Novo Nordisk Overweight | Barclays Capital | |
05.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.08.22 | Novo Nordisk Buy | Deutsche Bank AG | |
04.08.22 | Novo Nordisk Overweight | Barclays Capital | |
03.08.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
18.07.22 | Novo Nordisk Overweight | Barclays Capital | |
14.07.22 | Novo Nordisk Outperform | Bernstein Research | |
13.07.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
24.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
21.06.22 | Novo Nordisk Buy | Deutsche Bank AG | |
16.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
13.06.22 | Novo Nordisk Overweight | Barclays Capital | |
08.06.22 | Novo Nordisk Buy | Deutsche Bank AG | |
07.06.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
24.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
12.05.22 | Novo Nordisk Overweight | Barclays Capital | |
11.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
05.05.22 | Novo Nordisk Outperform | Bernstein Research | |
05.05.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. |
Werbung
Werbung